| 000 | 01791 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516140630.0 | ||
| 264 | 0 | _c20131227 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkt053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTheodorou, Konstantina | |
| 245 | 0 | 0 |
_aEfficacy of rifampicin in the treatment of experimental acute canine monocytic ehrlichiosis. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cJul 2013 |
||
| 300 |
_a1619-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBacterial Load |
| 650 | 0 | 4 |
_aBlood _xmicrobiology |
| 650 | 0 | 4 |
_aBone Marrow _xmicrobiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDog Diseases _xdrug therapy |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEhrlichia canis _xisolation & purification |
| 650 | 0 | 4 |
_aEhrlichiosis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpleen _xmicrobiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMylonakis, Mathios E | |
| 700 | 1 | _aSiarkou, Victoria I | |
| 700 | 1 | _aLeontides, Leonidas | |
| 700 | 1 | _aKoutinas, Alexander F | |
| 700 | 1 | _aKoutinas, Christos K | |
| 700 | 1 | _aKritsepi-Konstantinou, Maria | |
| 700 | 1 | _aBatzias, George | |
| 700 | 1 | _aFlouraki, Eugenia | |
| 700 | 1 | _aEyal, Osnat | |
| 700 | 1 | _aKontos, Vassilios | |
| 700 | 1 | _aHarrus, Shimon | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 68 _gno. 7 _gp. 1619-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkt053 _zAvailable from publisher's website |
| 999 |
_c22567612 _d22567612 |
||